(VIANEWS) – Shares of BIOSENIC (BEL 20: BIOS.BR) jumped by a staggering 16.28% to €0.12 at 10:11 EST on Tuesday, after two sequential sessions in a row of losses. BEL 20 is jumping 0.29% to €3,908.28, following the last session’s upward trend. This seems, up until now, a somewhat positive trend trading session today.
About BIOSENIC
BioSenic S.A., a biotech company, focuses on developing clinical assets. Its technologies include cutting-edge allogeneic cell and gene therapy platform with differentiated bone marrow sourced mesenchymal stromal cells, which can be stored at the point of use in the hospital; and Arsenic TriOxide platform for use in immuno-oncology to treat graft-versus-host disease, systemic lupus erythematosus, and systemic sclerosis. The company's investigational medicinal product is ALLOB, which is in a Phase IIb clinical trial in patients with difficult tibial fractures. The company is based in Mont-Saint-Guibert, Belgium.
Volatility
BIOSENIC’s last week, last month’s, and last quarter’s current intraday variation average was a positive 3.50%, a negative 0.36%, and a positive 4.93%.
BIOSENIC’s highest amplitude of average volatility was 5.29% (last week), 4.87% (last month), and 4.93% (last quarter).
More news about BIOSENIC (BIOS.BR).
